Trends in Biotechnology
Volume 14, Issue 10, October 1996, Pages 376-387
Journal home page for Trends in Biotechnology

Focus
Antisense oligonucleotides: towards clinical trials

https://doi.org/10.1016/0167-7799(96)10053-6Get rights and content

Antisense oligonucleotides have the ability to selectively block disease-causing genes, thereby inhibiting production of disease-associated proteins. The specificity and application of antisense oligonucleotides have been strongly validated in animal models for various disease targets. Based on the pharmacological, pharmacodynamic and pharmacokinetic profiles, the first generation of antisense oligonucleotides — phosphorothioates — have reached the stage of human clinical trials for various diseases. While ongoing human clinical trials are being carried out to further establishing the safety and efficacy of these oligonucleotides, the experience gained is providing a basis for designing a second generation of antisense oligonucleotides.

References (94)

  • WeissB. et al.

    Neuroscience

    (1993)
  • MetelevV. et al.

    Bioorg. Med. Chem. Lett.

    (1994)
  • MoniaB.P.

    J. Biol. Chem.

    (1993)
  • AgrawalS. et al.

    Curr. Opin. Biotechnol.

    (1995)
  • AkhtarS. et al.

    Trends Cell Biol.

    (1992)
  • ItohH. et al.

    Biochem. Biophys. Res. Commun.

    (1992)
  • RykovaE.Y. et al.

    FEBS Lett.

    (1994)
  • ZhangR.

    Biochem. Pharmacol.

    (1995)
  • RappaportJ.

    Kidney Int.

    (1995)
  • ZhangR.

    Biochem. Pharmacol.

    (1995)
  • AgrawalS.

    Biochem. Pharmacol.

    (1995)
  • AgrawalS.

    Trends Biotechnol.

    (1992)
  • ZhaoQ. et al.

    Biochem. Pharmacol.

    (1996)
  • ZamecnikP.C. et al.
  • ZamecnikP.C.

    Antisense Therapeutics

  • OffenspergerW.B.

    EMBO J.

    (1993)
  • NesterovaM. et al.

    Nat. Med.

    (1995)
  • DeanN.M. et al.
  • TomitaN.

    Hypertension

    (1995)
  • LeonettiC.

    J. Natl. Cancer Inst.

    (1993)
  • SkutellaT. et al.

    Exp. Clin. Endocrinol.

    (1995)
  • LandgrafR.

    J. Neurosci.

    (1995)
  • JansenB.

    Antisense Res. Dev.

    (1995)
  • TangJ-Y. et al.

    Nucleosides Nucleotides

    (1995)
  • KoziolkiewiczM. et al.

    Nucleic Acids Res.

    (1995)
  • GilesR.V. et al.

    Antisense Res. Dev.

    (1995)
  • MillerP.S. et al.

    Antisense Research and Applications

  • SannP.S. et al.
  • AgrawalS. et al.
  • MarshallW.S. et al.
  • GryznovS.

    Nucleic Adds Res.

    (1996)
  • AgrawalS. et al.

    Ann. New York Acad. Sci.

    (1992)
  • McKayR.A.

    Nucleic Acids Res.

    (1996)
  • KeanJ.M. et al.

    Biochemistry

    (1995)
  • LisziewiczJ.
  • TemsamaniJ. et al.

    Antisense Res. Dev.

    (1994)
  • GaoW.Y. et al.

    Mol. Pharmacol.

    (1993)
  • ZhaoQ. et al.

    Antisense Res. Dev.

    (1993)
  • WagnerR.W. et al.

    Science

    (1993)
  • LisziewiczJ. et al.
  • WangS. et al.
  • ThierryA.R. et al.

    Nucleic Acids Res.

    (1992)
  • ColigeA. et al.

    Biochemistry

    (1993)
  • CowsertL.M. et al.

    Antimicrob. Agents Chemother.

    (1993)
  • GoodarziG. et al.

    J. Gen. Virol.

    (1990)
  • WickstromE.L. et al.
  • Cited by (0)

    View full text